Abstract
The thyrotropin receptor (TSHR), a member of the large family of G protein–coupled receptors, controls both the function and growth of thyroid cells via stimulation of adenylyl cyclase. We report two different mutations in the TSHR gene of affected members of two large pedigrees with non–autoimmune autosomal dominant hyperthyroidism (toxic thyroid hyperplasia), that involve residues in the third (Val509Ala) and seventh (Cys672Tyr) transmembrane segments. When expressed by transfection in COS–7 cells, the mutated receptors display a higher constitutive activation of adenylyl cyclase than wild type. This new disease entity is the germline counterpart of hyperfunctioning thyroid adenomas, in which different somatic mutations with similar functional characteristics have been demonstrated.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vassart, G. & Dumont, J.E. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr. Rev. 13, 596–611 (1992).
Dumont, J.E., Lamy, F., Roger, P. & Maenhaut, C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72, 667–697 (1992).
Van Sande, J. et al. Thyrotropin activates both the cyclic AMP and the PIP2 cascades in CHO cells expressing the human cDNA of TSH receptor. Molec. Cell Endocrinol. 74, R1–R6 (1990).
Dumont, J.E., Jauniaux, J.C. & Roger, P.P. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem. Sci. 14, 67–71 (1989).
Dumont, J.E., Vassart, G. & Refetoff, S. in The Metabolic Basis of Inherited Diseases (eds Scriver C.R. et al.) 1843–1879 (McGraw-Hill, New York, 1989).
Lyons, J. et al. Two G protein oncogenes in human endocrine tumors. Science 249, 655–659 (1990).
Suarez, H.G. et al. gsp mutations in human thyroid tumours. Oncogene 6, 677–679 (1991).
O'Sullivan, C., Barton, C.M., Staddon, S.L., Brown, C.L. & Lemoine, N.R. Activating point mutations of the gsp oncogene in human thyroid adenomas. Molec. Carcinog. 4, 345–349 (1991).
Parma, J. et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365, 649–651 (1993).
Friedman, J.M. & Fialkow, P.J. in Werner's The Thyroid (eds Ingbar, S.H. & Braverman, L.E. ) 634–650 (Lippincott, Philadelphia, 1987).
Thomas, J.S. et al. Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol. Copenh. 100, 512–518 (1982).
Robinson, P.R., Cohen, G.B., Zhukovsky, E.A. & Oprian, D.D. Constitutively active mutants of rhodopsin. Neuron 9, 719–725 (1992).
Snenker, A. et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 369, 652–654 (1993).
Gross, B., Misrahi, M., Sar, S. & Milgrom, E. Composite structure of the human thyrotropin receptor gene. Biochem. Biophys. res. Commun. 177, 679–687 (1991).
Lathrop, G.M. & Lalouel, J.M. Easy calculations of lod scores and genetic risks on small computers. Am. J. hum. Genet. 36, 460–465 (1984).
Libert, F. et al. Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem. Biophys. res. Commun. 165, 1250–1255 (1989).
Cotecchia, S., Exum, S., Caron, M.G. & Lefkowitz, R.J. Regions of the alpha 1 adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. natn. Acad. Sci. U.S.A. 87, 2896–2900 (1990).
Kjelsberg, M.A., Cotecchia, S., Ostrowski, J., Caron, M.G. & Lefkowitz, R.J. Constitutive activation of the alpha 1B adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J. biol. Chem. 287, 1430–1433 (1992).
Samama, P., Cotecchia, S., Costa, T. & Lefkowitz, R.J. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J. biol. Chem. 268, 4625–4636 (1993).
Ren, Q., Kurose, H., Lefkowitz, R.J. & Cotecchia, S. Constitutively active mutants of the α2-adrenergic receptor. J. biol. Chem. 268, 16483–16487 (1993).
Kosugi, S. et al. Substitutions of different regions of the third cytoplasmic loop of the TSH receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and cAMP signal generation. Molec. Endocrinol. 7, 1009–1020 (1994).
Cohen, G.B., Yang, T., Robinson, P.R. & Oprian, D.D. Constitutive activation of opsin: influence of charge at position 134 and size at position 296. Biochemistry 32, 6111–6115 (1993).
Cohen, G.B., Oprian, D.D. & Robinson, P.R. Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296. Biochemistry 31, 12592–12601 (1992).
Kosugi, S. et al. Mutation of Alanine 623 in the third cytoplasmic loop of the rat TSH receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. J. biol. Chem. 267, 24153–24156 (1992).
Schertler, G.F., Villa, C. & Henderson, R. Projection structure of rhodopsin. Nature 362, 770–772 (1993).
Baldwin, J.M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12, 1693–1703 (1993).
Ruf, J., Carayon, P. & Lissitzky, S. Various expressions of a unique antihuman thyroglobuiin antibody repertoire in normal state and autoimmune disease. Eur. J. Immunol. 15, 268–272 (1985).
McKenzie, J.M. & Zakarijia, M. Clinical reviews: The clinical use of thyrotropin receptor antibody measurements. J. clin. endocrinol. Metab. 69, 1093–1096 (1989).
Robbins, L.S. et al. Pigmentation phenotypes of variant extension locus alleles results from point mutations that alter MSH receptor function. Cell 72, 827–834 (1993).
Leclere, J. et al. Behavior of thyroid tissue from patients with Graves' disease in nude mice. J. clin. endocrinol. Metab. 59, 175–177 (1984).
Leclere, J. & Thomas, J.L. Diffuse nonautoimmune hyperthyroidism. Ann. Endocrinol. Paris. 43, 553–568 (1982).
Brooker, G., Harper, J.F., Terasaki, W.L. & Moylan, R.D. Radioimmunoassy of cyclic AMP and cyclic GMP. Adv. Cyclic. Nucl. Res. 10, 1–33 (1979).
Berridge, M.J. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem. J. 212, 849–858 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Duprez, L., Parma, J., Van Sande, J. et al. Germline mutations in the thyrotropin receptor gene cause non–autoimmune autosomal dominant hyperthyroidism. Nat Genet 7, 396–401 (1994). https://doi.org/10.1038/ng0794-396
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0794-396
This article is cited by
-
Functional differences between TSHR alleles associate with variation in spawning season in Atlantic herring
Communications Biology (2021)
-
A new family with an activating mutation (G431S) in the TSH receptor gene: a phenotype discussion and review of the literature
International Journal of Pediatric Endocrinology (2014)
-
A Japanese family with nonautoimmune hyperthyroidism caused by a novel heterozygous thyrotropin receptor gene mutation
Pediatric Research (2014)
-
Lack of association between autonomously functioning thyroid nodules and germline polymorphisms of the thyrotropin receptor and Gαs genes in a mild to moderate iodine-deficient Caucasian population
Journal of Endocrinological Investigation (2014)
-
Sporadic congenital nonautoimmune hyperthyroidism caused by P639S mutation in thyrotropin receptor gene
European Journal of Pediatrics (2012)